Earlier this month, researchers reported unpublished preliminary findings from a pilot drug trial for ADNP syndrome, a rare genetic condition often accompanied by autism.
During the nearly year-long trial, 10 children with the condition, aged 6 to 12, took a low dose of ketamine. The drug is approve…